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Abstract: Diet-induced thermogenesis (DIT) is believed to be largely related to ATP production,
which is dependent on phosphorus (P) availability. We aimed to test the effect of P addition on
DIT of lean and overweight/obese healthy subjects. DIT was measured with or without P in
10 lean and 13 overweight/obese adults in a double-blind randomized cross-over pilot study with
one week washout period. After 10 h overnight fast, resting metabolic rate, respiratory quotient,
and substrate utilization were measured at fasting and every 30 min for 3 h after subjects drank a
standardized glucose solution, with P (500 mg) or placebo pills. Subjective ratings of hunger and
satiety were assessed before and after the end of each experiment using validated visual analogue
scale (VAS) questionnaires. Overweight/obese subjects had a blunted DIT with placebo, while P
supplementation induced a 23% increase in their DIT area under the curve (p < 0.05), which was
associated with a significant increase in carbohydrate oxidation. Subjects had lower appetite following
P supplementation, which was expressed as a significantly (p = 0.02) lower desire to eat a meal
(4.0 ± 0.7 cm) compared with placebo (5.8 ± 0.9 cm). P supplementation recovers the blunted
diet-induced thermogenesis in overweight and obese subjects and enhances their postprandial satiety.
Keywords: phosphorus; supplementation; diet induced thermogenesis; obesity; energy expenditure;
energy balance
1. Background
Diet induced thermogenesis (DIT) is the increase in energy expenditure above the basal resting
rate that takes place after the ingestion of food components. It accounts for 5%–15% of total energy
expenditure [1], and is the highest for protein-rich foods [2].
There is a large body of evidence that shows a blunted or reduced DIT in obese
individuals [3–7]—especially those with diabetes [8]—that was normalized after weight loss [6,7].
Therefore, insulin resistance and/or insulin shortage plays a role in postprandial adenosine
triphosphate (ATP) production [9], most likely by reducing the peripheral uptake of substrates needed
for its production—mainly glucose and phosphorus [10]. This triggers a vicious cycle, since phosphorus
depletion also appears to induce insulin resistance and glucose intolerance in animals [11]. Similarly,
an inverse relationship was observed in humans between serum phosphate levels and glucose levels
and homeostatic model assessment of insulin resistance index (HOMA-IR) [12–14]. In line with this,
the addition of phosphorus to meals was shown to improve HOMA-IR in rodents [15,16]. We have
also recently demonstrated that meal P supplementation improves postprandial glucose tolerance in
healthy men [17].
On the other hand, obese subjects taking P supplementation in a weight reducing program
had an increase in their basal metabolic rate [18,19]. Similar results were recently reported in rats,
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whereby the administration of a high phosphorus diet for four weeks induced thermogenesis by
increasing uncoupling protein-1 (UCP-1) expression in brown adipose tissue [16]. However, few studies
examining the effect of P supplementation of DIT in humans have been conducted. Only two studies
on older postmenopausal women have revealed that the addition of P to meals increased postprandial
thermogenesis in obese but not lean women [20,21]. No other study looked at the impact on younger
lean or obese men and women.
Postprandial ATP production in the liver has also been linked to signaling satiety, whereby
changes in hepatic energy status are transmitted via hepatic vagal afferent activity to the central
nervous system [22–26]. Accordingly, an analysis of the metabolic data using the Knowledge Discovery
in Databases have reached the conclusion that decreased energy levels or ATP deficiency were strongly
linked to the development of obesity by driving overeating and conserving energy [27]. We have also
recently found that the addition of 500 mg P to different preloads led to substantial reduction in ad
libitum subsequent energy intake (27%–33%) [28]. Therefore, in addition to its aforementioned role in
thermogenesis and insulin sensitivity, the effect of P on food intake can explain the reported inverse
relationship between P status, obesity, and metabolic syndrome [13,29–33].
More studies are warranted to investigate the relationship between P intake and DIT and satiety
in the context of obesity and insulin resistance in young adults. Therefore, the objective of the present
study was to test the effect of P supplementation on diet-induced thermogenesis and satiety after the
ingestion of glucose solution in lean and overweight/obese healthy men and women.
2. Experimental Section
2.1. Study Design and Participants
The experimental design is a double blind randomized cross over design, whereby each subject
was studied twice (two experimental sessions) with a minimum of 1-week washout period. A total
of 10 lean and 13 overweight and obese (herein referred to only as obese) adults were recruited.
Subjects were healthy, non-smokers, sedentary [34], with stable body weight for the past 3 months,
not following a special diet (confirmed by multi-pass 24-h recall), and not taking any medication that
affects metabolism. Subjects were asked to stop caffeine one week before the experiment.
2.2. Experimental Protocol
After 10 h overnight fast and after signing the consent form detailing the study’s purpose and
protocol, weight, height, and body composition (Tanita BC-418, Tanita Corporation, Tokyo, Japan)
were measured using standard procedures. Thereafter, resting metabolic rate (RMR) was measured
using indirect calorimetry (Cosmed Fitmate, Rome, Italy). Subjects were then asked to drink a standard
75 g glucose solution (TRUTOL® Glucose Tolerance Beverages, Thermo Fisher Scientific Inc., Waltham,
MA, USA) with 500 mg phosphorus pills (potassium phosphate, 23% monobasic and 18% dibasic) on
the first experiment and placebo pills (Cellulose) on the second one (Nutricap Labs, Farmingdale, NY,
USA). Using indirect calorimetry, diet-induced thermogenesis was assessed afterwards by measuring
RMR every 30 min for the following 3 h. Respiratory quotient (RQ = VCO2/VO2) was calculated
at fasting and postprandially from the volumes of oxygen consumed and carbon dioxide produced.
Substrate utilization—namely carbohydrate and fat oxidation—were also calculated from non-protein
RQ [35].
2.3. Questionnaires
At the end of the experiment, subjective appetite scores were collected from the subjects, using
visual analogue scale (VAS) questionnaires [36]. Moreover, habitual P intake (within the past month)
was assessed for all subjects using a culturally-specific semi-quantitative food frequency questionnaire
(FFQ) that included P-rich food items (both natural and processed), categorized into meat and
poultry, fish and shellfish, milk and dairy products, nuts and seeds, legumes, grain products, and
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carbonated non-alcoholic beverages. Data from the multi-pass 24-h recall and from the FFQ were
analyzed for energy and nutrient analysis using Nutritionist Pro™ Diet Analysis Software version 5.1
(Axxya Systems LLC, Woodinville, WA, USA).
This study was approved by the Institutional Review Board of the Lebanese American University.
2.4. Statistics
Data are reported as Mean ± SEM. Two-tailed independent t-test was performed to compare
data between lean and obese groups. Paired t-test was used for comparisons between P and placebo
experiments. Repeated measures were performed to analyze within-subject results for diet-induced
thermogenesis. Pearson’s correlation was used to compute the bivariate relations between BMI and
P intake. Based on the effect size and SD difference from the study by Khattab et al. (2015) [17],
a minimum of 10 subjects are needed to achieve 90% power with two-sided 5% significance level.
All data were analyzed with the SPSS version 23 statistical package, and statistical significance was
defined as p < 0.05.
3. Results
Subject characteristics are presented in Table 1. Obese subjects had significantly higher weight,
BMI, fat percentage, and resting metabolic rate (RMR) compared to lean subjects. Fat free mass
(FFM) was not different between groups, and thus RMR was not corrected for FFM. Daily energy
intakes estimated from multi-pass 24 h recall did not differ between groups. However, phosphorus
intake estimated from the FFQ normalized per 1000 ingested calories was significantly higher in lean
compared to obese subjects. Baseline characteristics of lean and obese subjects were similar between
the two experimental sessions (P and placebo).
Table 1. Subject characteristics.
Lean (n = 10) Obese (n = 13)
Age (years) 21 ± 1 22 ± 1
Sex (M/F) 5/5 5/8
Weight (kg) 71.6 ± 6.5 89.0 ± 1.9 *
Height (cm) 173.8 ± 4.8 170.8 ± 2.2
BMI (kg/m2) 23.0 ± 0.9 30.6 ± 0.8 *
FFM (kg) 57.5 ± 5.3 56.5 ± 2.5
Fat mass percentage (%) 20.0 ± 2.3 36.3 ± 2.1 *
Baseline RMR (kcal/min) 1.25 ± 0.08 1.44 ± 0.05 *
Daily energy intake (kcal) † 2256 ± 163 2521 ± 160
Daily dietary phosphorus (mg/1000 kcal) ‡ 615.3 ± 56.49 460.5 ± 39.04 *
Daily dietary calcium (mg/1000 kcal) † 415.4 ± 58.7 438.4 ± 31.2
Data are Mean ± SEM; * p < 0.05 vs. Lean (Independent t-test); † using multi-pass 24 h recall; ‡ using food
frequency questionnaire. BMI: body mass index; FFM: fat free mass; RMR: resting metabolic rate.
Figure 1 shows RMR measured at baseline and for 3 h after the ingestion of 75 g glucose solution
in lean and obese subjects, with P or with placebo. RMR of lean subjects significantly increased
above baseline with or without phosphorus (repeated measures) (Figure 1A), but area under the curve
(kcal/180 min) did not differ between experiments (Figure 1B). P supplementation was associated
with significantly higher RMR at 30 min in lean subjects as compared to placebo (independent t-test).
Obese subjects had a blunted DIT with placebo, as RMR did not change from baseline over 3 h after
ingestion of glucose solution (p > 0.05 using repeated measures) (Figure 1A), while P supplementation
resulted in significant increase in RMR above baseline such that area under the curve was 23% higher
compared with placebo (p < 0.05) (Figure 1B). Moreover, RMR of obese subjects at 30 and 90 min after
glucose ingestion was significantly higher with P vs. placebo (independent t-test) (Figure 1A).
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Figure  1.  Diet-induced  thermogenesis  after  drinking  75  g  glucose  solution  with  and  without 
phosphorus supplementation in lean and obese subjects. (A) Resting metabolic rate at baseline and 
over 3 h (180 min) after drinking 75 g glucose solution in lean and obese subjects with phosphorus 
(solid lines) or placebo (dashed lines); (B) Total area under the curve of RMR over 3 h (180 min) after 
drinking 75 g glucose solution with phosphorus  (solid bars) or placebo  (dashed bars)  in  lean and 
obese subjects. Data are Mean ± SEM. * p < 0.05 vs. placebo (paired t‐test); † p < 0.05: within‐subjects 
comparison  (repeated measures); NS: not significant  (repeated measures); RMR:  resting metabolic 
rate; AUC: area under the curve; SEM: standard error of the mean. 
Substrate  utilization  is  presented  in  Table  2.  The  obese  group  had  significantly  higher  fat 
oxidation at baseline compared to the lean group. After drinking 75 g glucose solution, carbohydrate 
oxidation  was  significantly  increased,  while  fat  oxidation  was  suppressed,  consistent  with  a 
significant increase in RQ. P supplementation did not affect the rate of substrate oxidation in lean 
subjects. On the other hand, postprandial fat oxidation in obese subjects was more suppressed in the 
placebo experiment compared  to  lean  (58% vs. 36% suppression), but  this was not observed with 
phosphorus (31% suppression). In addition, P supplementation resulted in a significant increase in 
carbohydrate oxidation in obese subjects. 
Table 2. Baseline and postprandial substrate utilization. 
  Lean Obese 
Placebo Phosphorus Placebo Phosphorus
Carbohydrate oxidation         
Baseline (mg/min)  86.5 ± 12.4  77.4 ± 4.8  90.6 ± 5.9  87.6 ± 3.1 
Postprandial (mg/min)  177.9 ± 13.3 182.0 ± 14.4 178.1 ± 10.5 207.6 ± 10.4 †
% Change from baseline  121 ± 17  134 ± 10  107 ± 10  139 ± 12 
Fat oxidation   
Baseline (mg/min)  100.3 ± 8.5  106.5 ± 6.6  125.2 ± 6.4 *  123.7 ± 3.7 * 
Postprandial (mg/min)  73.5 ± 4.6  75.3 ± 5.3  79.6 ± 4.5  85.3 ± 3.9 
% Change from baseline  −36 ± 7 −30 ± 1 −58 ± 9 * −31 ± 2 † 
Data are Mean ± SEM; * p < 0.05 vs. Lean (Independent t‐test); † p < 0.05 vs. placebo (paired t‐test). RQ: 
respiratory quotient (VCO2/VO2).   
Figure 1. Diet-induced thermogenesis after drinking 75 g glucose solution with and without
phosphorus supplementation in lean and obese subjects. (A) Resting metabolic rate at baseline and
over 3 h (180 min) after drinking 75 g glucose solution in lean and obese subjects with phosphorus
(solid lines) or placebo (dashed lines); (B) Total area under the curve of RMR over 3 h (180 min) after
drinking 75 g glucose solution with phosphorus (solid bars) or placebo (dashed bars) in lean and
obese subjects. Data are Mean ± SEM. * p < 0.05 vs. placebo (paired t-test); † p < 0.05: within-subjects
comparison (repeated measures); NS: not significant (repeated measures); RMR: resting metabolic rate;
AUC: area under the curve; SEM: standard error of the mean.
Substrate utilization is presented in Table 2. The obese group had significantly higher fat
oxidation at baseline compared to the lean group. After drinking 75 g glucose solution, carbohydrate
oxidation was significantly increased, while fat oxidation was suppressed, consistent with a significant
increase in RQ. P supplementation did not affect the rate of substrate oxidation in lean subjects.
On the other hand, postprandial fat oxidation in obese subjects was more suppressed in the placebo
experiment compared to lean (58% vs. 36% suppression), but this was not observed with phosphorus
(31% suppression). In addition, P supplementation resulted in a significant increase in carbohydrate
oxidation in obese subjects.
Table 2. Baseline and postprandial substrate utilization.
Lean Obese
Placebo Phosphorus Placebo Phosphorus
Carbohydrate oxidation
Baseline (mg/min) 86.5 ± 12.4 77.4 ± 4.8 90.6 ± 5.9 87.6 ± 3.1
Postprandial (mg/min) 177.9 ± 13.3 182.0 ± 14.4 178.1 ± 10.5 207.6 ± 10.4 †
% Change from baseline 121 ± 17 134 ± 10 107 139 ± 12
Fat oxidation
Baseline (mg/min) 100.3 ± 8.5 106.5 ± 6.6 125.2 ± 6.4 * 123.7 ± 3.7 *
Postprandial (mg/min) 73.5 ± 4.6 75.3 ± 5.3 79.6 ± 4.5 85.3 ± 3.9
% Change from baseline −36 ± 7 −30 ± 1 −58 ± 9 * −31 ± 2 †
Data are Mean ± SEM; * p < 0.05 vs. Lean (Independent t-test); † p < 0.05 vs. placebo (paired t-test).
RQ: respiratory quotient (VCO2/VO2).
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Subjective appetite scores measured using VAS at the end of the experiment showed higher
appetite and lower hunger with phosphorus supplementation versus placebo (Figure 2), which was
statistically significant (p < 0.05) for the “desire to eat a meal” and the “desire to eat something savory”.
Nutrients 2016, 8, 801  5 of 9 
 
Subjective appetite scores measured using VAS at  the end of  the experiment showed higher 
appetite and lower hunger with phosphorus supplementation versus placebo (Figure 2), which was 
statistically  significant  (p  <  0.05)  for  the  “desire  to  eat  a meal”  and  the  “desire  to  eat  something 
savory”.   
 
Figure 2. Subjective appetite scores of lean (gray) and obese (black) subjects, 3 h after drinking 75 g 
glucose  solution with phosphorus  (solid  bars)  or placebo  (dashed  bars)  supplementation. Visual 
analog scale (VAS) questionnaires. Data are Mean ± SEM. * p < 0.05 vs. placebo (paired t‐test). SEM: 
standard error of the mean   
In addition,  there was an  inverse correlation between daily P  intake  (per 1000 kcal) assessed 
using  the FFQ and BMI  (r =  −0.48, p = 0.024)  (Figure 3) after pooling all  lean and obese  subjects 
together.   
 
Figure 3. Pearson’s bivariate correlation between BMI of lean and obese subjects pooled together and 
daily  phosphorus  intake  (mg/1000  kcal)  estimated  from  food  frequency  questionnaire  (FFQ). 
Pearson’s r = −0.48, p = 0.024. BMI: body mass index. 
  
Figure 2. Subjective appetite scores of lean (gray) and obese (black) subjects, 3 h after drinking 75 g
glucose solution with phosphorus (solid bars) or placebo (dashed bars) supplementation. Visual analog
scale (VAS) questionnaires. Data are Mean ± SEM. * p < 0.05 vs. placebo (paired t-test). SEM: standard
error of the mean.
In addition, there was an inverse correlation between daily P intake (per 1000 kcal) assessed using
the FFQ and BMI (r = −0.48, p = 0.024) (Figure 3) after pooling all lean and obese subjects together.
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4. Discussion
To our knowledge, this pilot study is the first investigating the effect of P supplementation on
DIT in lean and obese young healthy men and women. Addition of P to glucose solution resulted in
an increase in DIT compared with placebo in both lean and obese subjects. The increase was more
pronounced in obese individuals, probably because they had a blunted DIT with placebo, whereby
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postprandial energy expenditure did not differ from fasting baseline. Lower DIT in obese individuals
compared to lean was previously found [3–7], and was restored after weight loss [6,7]. This was
attributed to impaired glucose tolerance and/or insulin resistance associated with excess body fat,
which is improved with weight loss. On another note, chronic hypophosphatemia was shown to
be inversely associated with insulin sensitivity and glucose tolerance in healthy subjects [12–14,37].
Conversely, a diet high in phosphorus improved HOMA-IR in db-db mice after 8 weeks [15] and
healthy rats after 4 weeks [16]. We have reported similar results in humans, whereby meal phosphorus
supplementation resulted in an immediate improvement in postprandial glucose tolerance in healthy
subjects [17]. Since meal supply of metabolites—including that of phosphorus—is known to affect
hepatic ATP production [38,39], we propose that phosphorus supplementation in the present study
might have increased insulin sensitivity and subsequent phosphorus and glucose uptake by the liver,
resulting in an increased ATP production and thermogenesis. Since obese subjects are more prone
to insulin resistance than lean subjects, the observed effect on thermogenesis was higher in obese
subjects. This is supported by our findings on substrate utilization, whereby P supplementation was
associated with a significant increase in carbohydrate oxidation in obese compared to placebo, while
this effect was not observed in lean. Fat oxidation in obese was also less suppressed postprandially
with P compared to placebo, suggesting that P supplementation induced more carbohydrate and fat
utilization, resulting in higher DIT. Nevertheless, we have not tested for insulin sensitivity or glucose
tolerance in our study, and thus this needs to be further explored in future experiments. Another
proposed mechanism is supported by a recent animal study showing that rats fed a high phosphorus
diet (1.2%) for 8 weeks had increased thermogenesis compared to controls, which was manifested by
increased UCP-1 expression in brown adipose tissue (BAT) [16]. Although thermogenesis in BAT is
most accurately assessed using positron emission tomography (PET) imaging, it was reported to be
directly associated with an increase in VO2 consumption and energy expenditure measured using
indirect calorimetry in humans [40], which validates our assumptions.
Our results are in line with those by Jaedig et al. (1994) [21] and Kaciuba-Us´ciłko et al. (1993) [18],
which showed higher resting and postprandial thermogenesis with phosphate supplementation in
older obese but not lean women. The amount of P in the supplements (~1000 mg) used in the latter
studies was double that in the present study (500 mg). Moreover, we used a potassium phosphate
supplement, while in the study by Jaedig et al. (1994) [21], both potassium and magnesium phosphate
produced the same effect, suggesting that it is phosphate rather than potassium that is mediating the
observed changes.
Postprandial subjective appetite of lean and obese subjects was suppressed compared to placebo
in the present study, 3 h after the ingestion of glucose solution with the addition of phosphorus. This
is in line with our previous findings, whereby phosphorus addition to different carbohydrate preloads
resulted in lower subsequent ad libitum energy intake in lean individuals [28]. Longer-term effects
of P supplementation on appetite was also observed in obese individuals, 3 months after daily P
supplementation (375 mg) with meals [41]. In line with this, “phosphate appetite” was previously
reported among rats fed low P diet for 1 week [42,43]. We suggest that the aforementioned mechanism
related to P inducing higher hepatic ATP [38,39] might also contribute to higher satiation, since
increased ATP in the liver is believed to transmit afferent neural signals to the central nervous system,
resulting in a suppressed appetite [22–26].
Interestingly, usual dietary P intake of lean subjects assessed using FFQ was significantly higher
than that of obese group. This difference could not have affected baseline P, since fasting serum P is
tightly controlled in healthy humans and is not affected by diet [23,44]. Therefore the effect of dietary
P is only evident postprandially, when serum P rises in response to a meal, but then homeostatic
mechanisms are activated to normalize it back to baseline [17]. Therefore, the observed effect of P in
the present study is only due to meal P supplementation.
Taken together, our findings support a role of P in regulating energy metabolism, and thus in the
management of obesity. Indeed, an inverse correlation between P intake and BMI was observed in
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our study when data from lean and obese subjects were pooled together, albeit our small sample size.
Consistently, this was widely reported in the literature in both animal [16] and human observational
studies [12,13,29–33], and was supported by our recent clinical trial on obese individuals, whereby
daily meal phosphorus supplementation for 3 months was associated with lower body weight, BMI,
and waist circumference compared with controls [23]. This partially explains the fact that the highly
available and consumed contemporary obesogenic diets are rich in fat and refined carbohydrates but
low in P, while protein-rich foods that are also high in P are known to increase thermogenesis and
satiety [45]. It should be noted that daily P intake in our participants (1100± 108 mg/day) did cover the
recommended dietary allowance for P (RDA = 700 mg/day) [46], consistent with usual reported current
intakes with modern diets that are rich in processed foods [47]. However, when expressed per kcal of
ingested energy, reported usual P intake in the present study and in the literature (0.5–0.6 mg P/kcal)
is significantly lower than that found in traditional diet regimens rich in natural unprocessed foods
(1 mg P/kcal) [47]. Interestingly, these latter diets are associated with lower BMI, which supports the
argument that the modern diet that is high in fat and sugar lacks sufficient P needed to process the
extra ingested energy.
Limitations of the present study include that it is a pilot study lacking assessments of potential
mechanism(s) of action—especially regarding insulin sensitivity, glucose tolerance, hepatic ATP, and
objective measures of appetite. Strengths include our original findings with respect to the P effect
on DIT in lean and obese healthy adults and the cross-over double-blinded nature of the design that
reduces bias. Future studies are warranted to replicate results in longer-term studies with large sample
size and to investigate mechanism(s) of action.
5. Conclusions
Phosphorus supplementation increases postprandial thermogenesis in lean and obese adults,
with a more pronounced effect among obese subjects. Phosphorus also promotes fullness in obesity.
Our findings set the stage for meal P supplementation or fortification as a promising obesity treatment
at moderate levels (500 mg P per meal), which are far below the upper safe level of intake (4 g) [43].
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